SCHEMBL6171882

SCHEMBL6171882

CC1(C)C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1C(N)c1ccnc(C(=O)c2ccco2)c1

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.46
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
CA9 Q16790 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171681 0.82 IGF1R (0.43) IGF1RCA1CA2CA4CA9
SCHEMBL2942281 0.72 IGF1R (0.58) IGF1R
SCHEMBL2940717 0.72 IGF1R (0.73) IGF1R
SCHEMBL6171845 0.70 IGF1R (0.46) IGF1R
SCHEMBL2935470 0.70 IGF1R (0.62) IGF1R
SCHEMBL6173911 0.69 IGF1R (0.42) IGF1R
SCHEMBL6175950 0.69 CA1 (0.35) IGF1RCA1CA2CA4CA9
SCHEMBL2939713 0.69 IGF1R (0.63) IGF1R
SCHEMBL2939900 0.68 IGF1R (0.59) IGF1R
SCHEMBL2942844 0.68 IGF1R (0.74) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed